241 related articles for article (PubMed ID: 22506441)
1. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
Pratheesh PJ; Praharaj SK; Srivastava A
Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
[TBL] [Abstract][Full Text] [Related]
2. Fluvoxamine-Associated Galactorrhea: A Case Report.
Chakladar A; Singh J; Tak NK; Patra BN; Sagar R
J Clin Psychopharmacol; 2020; 40(1):101-102. PubMed ID: 31804454
[No Abstract] [Full Text] [Related]
3. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.
Dwivedi S; Pavuluri M; Heidenreich J; Wright T
J Child Adolesc Psychopharmacol; 2002; 12(1):69-70. PubMed ID: 12014598
[No Abstract] [Full Text] [Related]
4. Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Yoshimura R; Kaneko S; Shinkai K; Nakamura J
Psychiatry Clin Neurosci; 2006 Jun; 60(3):389-93. PubMed ID: 16732759
[TBL] [Abstract][Full Text] [Related]
5. A case with euprolactinemic galactorrhea induced by escitalopram.
Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
[TBL] [Abstract][Full Text] [Related]
6. Gynecomastia with risperidone-fluoxetine combination.
Benazzi F
Pharmacopsychiatry; 1999 Jan; 32(1):41. PubMed ID: 10071182
[TBL] [Abstract][Full Text] [Related]
7. Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
Morinobu S; Yamashita H; Yamawaki S; Tanaka K; Ohkawa M
J Clin Psychiatry; 2002 Sep; 63(9):838-40. PubMed ID: 12363127
[No Abstract] [Full Text] [Related]
8. Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
McDougle CJ; Fleischmann RL; Epperson CN; Wasylink S; Leckman JF; Price LH
J Clin Psychiatry; 1995 Nov; 56(11):526-8. PubMed ID: 7592506
[TBL] [Abstract][Full Text] [Related]
9. Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.
Oulis P; Masdrakis VG; Karapoulios E; Karakatsanis NA; Kouzoupis AV; Konstantakopoulos G; Soldatos CR
World J Biol Psychiatry; 2009; 10(4 Pt 3):953-5. PubMed ID: 19224410
[TBL] [Abstract][Full Text] [Related]
10. Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl.
Vlatka BM; Branka AM; Branimir M
Gen Hosp Psychiatry; 2010; 32(4):e9-e10. PubMed ID: 20633737
[No Abstract] [Full Text] [Related]
11. Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.
Miyamoto S; Miyake N; Ogino S; Endo T; Yamaguchi N
Psychiatry Clin Neurosci; 2007 Dec; 61(6):702-3. PubMed ID: 18081639
[No Abstract] [Full Text] [Related]
12. A case of galactorrhea during paroxetine treatment.
Evrensel A; Önen Ünsalver B; Akyol A; Ceylan ME
Int J Psychiatry Med; 2016 Apr; 51(3):302-5. PubMed ID: 27284122
[TBL] [Abstract][Full Text] [Related]
13. Photosensitivity reaction associated with selective serotonin re-uptake inhibitors: possible cross-sensitivity?
Cheng YC; Huang MC
Psychiatry Clin Neurosci; 2014 Mar; 68(3):244. PubMed ID: 24895743
[No Abstract] [Full Text] [Related]
14. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder.
Harris E; Eng HY; Kowatch R; Delgado SV; Saldaña SN
J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):347-53. PubMed ID: 20807074
[TBL] [Abstract][Full Text] [Related]
15. Extended-release fluvoxamine (Luvox CR).
Med Lett Drugs Ther; 2008 Jun; 50(1289):50-1. PubMed ID: 18583947
[No Abstract] [Full Text] [Related]
16. Trazodone induced galactorrhea: a case report.
Arslan FC; Uysal EK; Ozkorumak E; Tiryaki A
Gen Hosp Psychiatry; 2015; 37(4):373.e1-2. PubMed ID: 25920951
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L; Eap CB
J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
[TBL] [Abstract][Full Text] [Related]
18. The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.
Pathak S; Cottingham EM; McConville BJ
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S93-4. PubMed ID: 12880505
[No Abstract] [Full Text] [Related]
19. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
Monteleone P; Catapano F; Bortolotti F; Maj M
Biol Psychiatry; 1997 Aug; 42(3):175-80. PubMed ID: 9232209
[TBL] [Abstract][Full Text] [Related]
20. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
